Considerable development in the application of injectable drug delivery systems for cancer therapy has occurred in the last few decades. These improvements include liposomes, lipid nanoparticles (LNPs), and other nanoparticles with or without macromolecular conjugates. For example, liposomal doxorubicin modified by poly(ethylene glycol) (Doxil) was the first liposome with anti-cancer effects which was approved by the US Food and Drug Administration, whereas Abraxane (modified albumin nanoparticles loaded by paclitaxel) was recently confirmed for the treatment of breast cancer. Recently, drug delivery systems by LNPs are an emerging technology with numerous advantages over conventional liposomes and chemotherapy using free drug treatment of cancer. These properties are biocompatibility, controlled and sustained release of anti-tumor drugs, and lower toxicity. Valuable experiments on these drug delivery systems offer better treatment of multidrug-resistant cancers and lower cardiotoxicity. LNPs have been presented with high functionality in chemotherapeutic targeting of breast and prostate cancer. The basis for this targeting behavior has been shown to be both passive and active targeting. The main objective of this review was an overview of the current position of the liposome-based drug delivery systems in targeted anticancer chemotherapy.
Introduction: In recent years, multidrug-resistance in bacteria has drastically increased and has posed a great threat to the human health. This problem has generated an urgent need to search alternatives for the treatment of MDR bacteria. It has been proved that metal nanoparticles (MNPs) and nanocomposites (MNCs) possess remarkable antimicrobial potential, and hence can be used in alternative therapy. Areas covered: This review is aimed to discuss recent reports on antibacterial activities of MNPs and MNCs against MDR bacteria. Expert opinion: Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, Acinetobacter baumannii, Klebsiella pneumoniae, Serratia marcescens, Streptococcus pneumoniae, and Staphylococcus epidermidis are important pathogenic bacteria which have shown multidrug resistance (MDR) against a wide range of conventional antibiotics. In this context, effects of metal nanopartilcles (MNPs) and metal nanocomposites (MNCs) on these pathogens have demonstrated considerable efficacy. Several mechanisms concerning activity of MNPs and MNCs against pathogenic bacteria which are mainly dependent on type of their precursors and treated bacterium have been investigated. In addition, many studies have been made on antibacterial activities of these nanomaterials with similar and different results.
Introduction: In the recent years, green synthesis is a novel method without some disadvantages of physical and chemical methods. In this approach, bacteria, archaebacteria, fungi, and plants may be applied without utilizing toxic and expensive materials for metal nanoparticles (MNPs) preparation. Methods: In this study, we used Taguchi method to obtain optimum conditions in titanium dioxide and zinc oxide nanoparticle (NPs) biosynthesis by Halomonas elongata IBRC-M 10214. Design and analysis of Taguchi experiments (an orthogonal assay and analysis of variance [ANOVA]) carried out by the Qualitek-4 software. Effects of TiO(OH)2, incubation temperature, and culturing time for synthesis of TiO2 NPs as well as ZnCl2 concentration, glucose concentration, and incubation temperature for preperation of ZnO NPs were evaluated as the controllable factors with 3 levels. Characterization of TiO2 and ZnO NPs were determined by UV-Vis spectroscopy, X-ray diffraction (XRD), Fourier transform infrared spectroscopy (FT-IR), scanning electron microscopy (SEM), and dynamic light scattering (DLS) analysis. Also, the antimicrobial properties of these NPs were investigated based on agar diffusion assay of NPs dispersed in batch cultures using Escherichia coli ATCC 25922 and Staphylococcus aureus ATCC 43300 as multidrug-resistant (MDR) bacteria. Results: It was evaluated that TiO2 and ZnO NPs had respectively average diameter sizes of 104.63±27.75 and 18.11±8.93 nm with spherical shapes. In contrast to the TiO2 NPs without antibacterial activity, the ZnO NPs had antibacterial effects at 0.1 and 0.01 M of (ZnCl2). Conclusion: The ZnO NPs have the antibacterial effect that can be operative in the medicinal aspect for fighting against prominent MDR bacteria such as E. coli ATCC 25922 and S. aureus ATCC 43300. In total, this study presents simple method in biosynthesis of TiO2 and ZnO NPs with low expense, eco-friendly, and high productivity properties.
27 June 2022 in Advances in Colloid and Interface Science
Recently, great attention has been paid to nano-composites of cellulose, due to their unique structure as a most abundant natural polymer with having exceptional properties such as renewable, biodegradable and high specific tensile strength, aspect ratio, and Young’s modulus. Prominent cellulose is naturally present in plant lignocellulosic biomass as a biocomposite made of cellulose, hemi-celluloses, lignin, etc. In addition, it can be extracted from other natural sources including bacteria, algae, and sea animals. Microcrystalline cellulose (MCC), nanocrystalline cellulose (NCC), and nanofibrillated cellulose (NFC) is an emerging renewable nanomaterial that has various applications, such as food, paper production, industrial and pharmaceutical biomaterials. The surface modification on NCC can improves its disperse ability in different solvents and its utilization in protein immobilization, tissue engineering, drug delivery, and inorganic reaction template. Therefore, based on recent studies, this review illustrated considerable progresses with addressing medicinal properties involving antimicrobial and biocompatibility of nano-cellulose (NC) in the case of wound healing.